Insulin Detemir
Insulins and Analogues For Injection, Long-Acting
Sold as Levemir · LEVEMIR PENFILL
- Drug class
- Insulins and Analogues For Injection, Long-Acting
- Availability
- See label
- Routes
- Subcutaneous
- Markets covered
- 3
- Products on record
- 39
Overview
Insulin Detemir is an active pharmaceutical ingredient in the Insulins and Analogues For Injection, Long-Acting group (A10AE). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 37 | May 15, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
| EU European Union | EMA | 1 | July 13, 2021 |
GBUnited Kingdom· MHRA
37 products
Uses
Levemir is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
How to take
CACanada· Health Canada
1 product
Uses
LEVEMIR® (insulin detemir) is indicated for: the treatment of type 1 diabetes mellitus in adults, adolescent and children 2 years and above; the treatment of type 2 diabetes mellitus in adults when insulin is required for the control of hyperglycemia; the treatment of type 2 diabetes mellitus in combination with oral anti-diabetic agents (OADs) in adults who are not in adequate metabolic control on OADs alone.
For safety reasons, the use of insulin in combination with thiazolidinedione is not indicated (See Warnings and Precautions); the treatment of adult patients with type 2 diabetes mellitus in combination with Victoza ® (liraglutide) and metformin when Victoza® and metformin do not achieve adequate glycemic control (see CLINICAL TRIALS).
Levemir® is also recommended in combination with short- or rapid-acting meal time insulin. 1 Pediatrics Pediatrics (<18 years of age): Evidence from clinical studies and experience suggests that use in the pediatric population is not associated with any differences in safety or effectiveness.
EUEuropean Union· EMA
1 product
Uses
Levemir is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
How to take
Drug interactions
Known interactions involving Insulin Detemir. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 316. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB046680371 · revised May 15, 2026
- [2]Health Canada (DPD) · 02271842 · revised March 22, 2025
- [3]European Medicines Agency · EMEA/H/C/000528 · revised July 13, 2021
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.